CLOSE X

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE4676.15106.5 (+2.33 %)
PREV CLOSE ( ) 4569.65
OPEN PRICE ( ) 4638.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 699
TODAY'S LOW / HIGH ( )4531.95 4696.45
52 WK LOW / HIGH ( )3950.5 5954
NSE4641.1063 (+1.38 %)
PREV CLOSE( ) 4578.10
OPEN PRICE ( ) 4505.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7396
TODAY'S LOW / HIGH( ) 4505.00 4698.00
52 WK LOW / HIGH ( )3975 5894.5
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 10-05 2023
Management Info
Amit Jain - Chairman Himanshu Bakshi - Managing Director
Registered Office

Address Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 45288855

Email igrc.schil@sanofi.com

Website www.sanofi.in

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
27Mar Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that it enclosed transcrip..
26Feb Sanofi Consumer Healthcare India’s net
Sanofi Consumer Healthcare India has reported results for fourth quarter..
20Feb Sanofi Consumer Healthcare India submi
Sanofi Consumer Healthcare India has informed that this is with referenc..
10Oct Sanofi Consumer Healthcare India inf
In accordance with Regulation 30 of the SEBI (Listing Obligations and Di..
05Aug Sanofi Consumer Healthcare India repor
Sanofi Consumer Healthcare India has reported result for second quarter..
Financials
in Crores
QTR Dec 25 ANNUAL 25
Net Profit66.5240.1
Gross Profit 90.5 320.3
Operating Profit 94.4327.4
Net Sales 251878.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
up  13047.00 (4.93%)
M.Cap ( in Cr)16739.16
Acutaas Chemicals (BSE)
up  2214.90 (4.92%)
M.Cap ( in Cr)18133.63
NGL Fine-Chem (BSE)
up  2240.65 (4.38%)
M.Cap ( in Cr)1384.28
Sanofi India (BSE)
up  3332.00 (2.05%)
M.Cap ( in Cr)7673.80
Glaxosmithkline Phar (BSE)
up  2347.00 (1.58%)
M.Cap ( in Cr)39759.60
Shareholding Pattern
PROMOTERS 71.27%
MUTUAL FUNDS/UTI 13.46%
NON-INSTITUTION 8.57%
FI/BANKS/INSURANCE 3.87%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
Bajaj Finserv Healthcare Fund-Reg(G)2.17
Sundaram Small Cap Fund(G)1.92
Bajaj Finserv Balanced Advantage Fund-Reg(G)1.59
Nippon India Pharma Fund(G)1.42
ICICI Pru Smallcap Fund(G)1.33
Aditya Birla SL Small Cap Fund(G)1.28
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)1.27
Attention Investors

Prevent unauthorised Transactions in your account —> Update your mobile numbers/email 10s with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...... Issued in the interest of Investors Prevent Unauthorized Transactions in your demat account—> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day Issued in the interest of investors. No need to issue cheques by investor while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of

KYC

KYC KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DR Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Compliance Officer : Mr. Kamesh Gupta. 011-43100999. kgupta@rkglobal.in / grievances@rkglobal.in - File a Complaint on SCORES

Registration Nos : SEBI Registration No . INZ000187132; Research Regn. No. : INH000002210; IN-DP-241-2016; NSDL: DP ID - IN 302453 (Delhi), IN 302951 (Kolkata); R K Global Shares & Securities Ltd CIN NO:U99999MH1995PTC174185;

Filing Complaints on SCORES - Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID. Benefits: Effective Communication, Speedy redressal of the grievances.

Copyrights 2020 © rkglobal.in - All Right Reserved

Designed,Developed & Content Powered by Accord Fintech Pvt Ltd.